BMO Capital analyst Juan Sanabria raised the firm’s price target on Chiron Real Estate (XRN) to $39 from $33 and keeps a Market Perform rating on the shares. The company pivoted decisively towards higher growth SHOP community acquisition, necessitating a second dividend cut and guidance withdrawal, but while the transition is initially dilutive, it may highlight the discounted value of the REIT’s legacy portfolio, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRN:
- Analyst Maintains Hold on XRN Amid Strategic Shift to Senior Housing and Elevated Near-Term Risk
- Global Medical REIT Bets Big on Senior Housing
- Chiron Real Estate Raises Capital via Preferred Stock Placement
- Chiron Real Estate price target lowered to $40 from $42 at Alliance Global
- Chiron Real Estate downgraded to Neutral from Buy at Compass Point
